Fig. 3: Administration of VEGFC mRNA-LNPs induces local lymphatic proliferation in mice in vivo. | Nature Communications

Fig. 3: Administration of VEGFC mRNA-LNPs induces local lymphatic proliferation in mice in vivo.

From: Nucleoside-modified VEGFC mRNA induces organ-specific lymphatic growth and reverses experimental lymphedema

Fig. 3

a–b Assessment of lymphatic proliferation 5 days after intradermal injection with 1 µg of Poly(C) or VEGFC mRNA-LNPs. EdU staining and anti-LYVE1 immunostaining of slides processed by paraffin-based histology (bars, 50 µm) shown by widefield (a) and confocal imaging (b). Arrows indicate EdU and LYVE1 double positive lymphatic endothelial cell (LEC) nuclei. Representative images of 3 ears of 3 mice in each group are shown. c Number of EdU positive LECs (two-tailed, unpaired T-test, P = 0.0260 for 3 mice) and mitotic index (two-tailed, unpaired T-test, P = 0.0266 for 3 mice) are shown 5 days after intradermal injection with 1 µg of Poly(C) or VEGFC mRNA-LNPs. Quantitative data for lymphatic proliferation are represented as mean and SEM from 3 injected ears of 3 mice in each group.

Back to article page